266 results on '"Sternieri E"'
Search Results
52. Treatment with naltrexone
53. Detoxification from opioids with clonidine, clonidine-naloxone and clonidine-naltrexone
54. Chronic headache and analgesic abuse
55. Abuso di sostanze psicoattive e sistema neuroendocrino dell’adolescente
56. Accanimento terapeutico o riduzione del danno
57. Prevalenza e frequenza dell’uso di cocaina in un campione di tossicodipendenti del territorio modenese
58. Naltrexone: aspetti di farmacologia ed applicazioni cliniche
59. Headache patients’ attitude toward analgesic drugs
60. Drug metabolism in liver cirrhosis: alterations of the time-course of plasma naltrexone levels after oral intake
61. Naltrexone and 6-Beta-naltrexol concentration/time profile in the treatment of opiate dependence
62. Serum levels of naltrexone and 6-beta-naltrexol after oral naltrexone in patients with liver cirrhosis
63. Plasma time-course of naltrexone and 6beta-naltrexol levels after oral administration in drug addicts and in patients with liver cirrhosis
64. Plasma reduced glutathione and cysteine levels in heroin addicts
65. Plasma time-course of naltrexone and 6beta-naltrexol after oral naltrexone administration in patients with liver cirrhosis
66. The decrease in plasma thiol groups in daily headache paracetamol abuser patients as possible factor of pain maintenance
67. Serum naltrexone and 6-beta naltrexol concentrations in detoxified addicts during long term naltrexone treatment
68. PHARMACOKINETICS OF NAPROXEN AFTER ORAL-ADMINISTRATION DURING AND OUT OF MIGRAINE ATTACKS
69. Intervento terapeutico globale nei confronti del tossicodipendente: farmacologico, psicoterapeutico, sociale
70. Activity of cromolyn sodium in dietary migraine: a double-blind placebo-controlled multicenter trial
71. DETERMINATION OF NALTREXONE AND 6-BETA-NALTREXOL IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH COULOMETRIC DETECTION
72. Activity of cromolyn sodium in dietary migraine: a double-blind placebo controlled multicenter trial
73. Studio epidemiologico sull’emicrania nei professionisti: primi risultati
74. Significato biologico e possibili applicazioni cliniche del glutatione
75. Modalità d’uso e tossicità delle associazioni analgesiche nei soggetti con cefalea cronica quotidiana
76. Chronic headache and family organization: a systemic methodology
77. Dapiprazole compared with clonidine and a placebo in detoxification of opiate addicts
78. Terapia delle cefalee, comportamento alimentare e serotonina
79. PHARMACOKINETICS OF TIAPROFENIC ACID AFTER ORAL-ADMINISTRATION IN FASTING PATIENTS DURING AND BETWEEN MIGRAINE ATTACKS
80. Trattamento farmacologico integrato per la terapia delle tossicodipendenze
81. Le cefalee alimentari nei secoli
82. Drug Addiction: a possible response to stressful events
83. Valutazione del contenuto plasmatico e possibile uso terapeutico del glutatione in pazienti con cefalea cronica quotidiana ed uso giornaliero di associazioni analgesiche
84. Active reporting scheme: an example to evaluate specific adverse drug reactions
85. Chronic headache, stress and family organization
86. Methadone—metabolism, pharmacokinetics and interactions
87. Oral Naltrexone Treatment for Cholestatic Pruritus: A Double-Blind, Placebo-Controlled Study
88. METHYLENEDIOXYAMPHETAMINE (MDA) AND METHYLENEDIOXYMETHAMPHETAMINE (MDMA OR ECSTASY) EXTERNAL QUALITY ASSESSMENT IN URINE DRUG TEST SCREENING.
89. Oral naltrexone treatment for cholestatic pruritus: A double-blind, placebo-controlled study
90. 2-21-11 Cirfac study: Validation of Italian guidelines for the treatment of migraine
91. Effects of Chronic Treatment with Phenazone on the Hot-Plate Test and [3H]Serotonin Binding Sites in Pons and Cortex Membranes of the Rat
92. Serum naltrexone and 6-beta-naltrexol concentrations in detoxified heroin addicts during long term naltrexone treatment
93. Energy state in the liver of rats with iron overload
94. The effect of acute ethanol intoxication to rats on the reduced glutathione content and lipid hydroperoxides production in liver mitochondria
95. Pharmacokinetics of naproben after oral administration during and out of migraine attacks
96. Pharmacokinetic of reduced glutathione in man: Effect on plasma cysteine and thiol compounds
97. Effects of Long-Term Treatment with Naltrexone on Hepatic Enzyme Activity
98. Bioavailability of different naltrexone formulations performed by a new electrochemical chromatographic method
99. Effects of Chronic Treatment with Phenazone on the Hot-Plate Test and [3H]Serotonin Binding Sites in Pons and Cortex Membranes of the Rat.
100. Thyroid inhibition by γ-amino-β-hydroxybutyric acid
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.